Biblio

Author Title [ Type

] Year

Filters: Author is Maeda, Yoshinobu [Clear All Filters]

Journal Article

Saeki K, Fujiwara H, Seike K, Kuroi T, Nishimori H, Tanaka T, Matsuoka K-I, Fujii N, Maeda Y. Sigle Agent of Posttransplant Cyclophosphamide Without Calcineurin Inhibitor Controls Severity of Experimental Chronic GVHD. Acta Med Okayama. 2024;78(2):123-134.

Teshima T, Onishi Y, Kato K, Taniguchi S, Miyamura K, Fukushima K, Kato J, Ishikawa T, Doki N, Nakamae H, et al. Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. Int J Hematol. 2024.

Kitamura W, Fujii N, Nawa Y, Fujishita K, Sugiura H, Yoshioka T, Fujiwara Y, Usui Y, Fujii K, Fujiwara H, et al. Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological S. Int J Hematol. 2022.

Komura A, Meguri Y, Matsubara C, Fujiwara H, Yukawa R, Hayashino K, Nakamura M, Yoshida C, Yamamoto K, Matsuoka K-I, et al. [Myelodysplastic syndrome with der (1;7)(q10;p10) complicated with eosinophilia and organizing pneumonia]. Rinsho Ketsueki. 2023;64(7):619-625.

Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, et al. The impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: A retrospective analysis from the JSHCT. Biol Blood Marrow Transplant. 2014.

Sumii Y, Kondo T, Ikegawa S, Fukumi T, Iwamoto M, Nishimura MFiliz, Sugiura H, Sando Y, Nakamura M, Meguri Y, et al. Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 2023;8(8).

Iwamuro M, Kondo T, Ennishi D, Fujii N, Matsuoka K-I, Takahashi T, Hirabata A, Tanaka T, Otsuka F, Maeda Y, et al. Feasibility of Flow Cytometry Analysis of Gastrointestinal Tract-Residing Lymphocytes in Hematopoietic Stem Cell Transplant Recipients. Acta Med Okayama. 2023;77(4):347-357.

Sumii Y, Fujii K, Kondo T, Urata T, Kimura M, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka K-I, et al. Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective study. Transfusion. 2023.

Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, et al. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04. Int J Hematol. 2016.

Nakagawa S-I, Nukii Y, Mochizuki K, Uchiyama A, Maeda Y, Kurokawa T. A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed. J Clin Exp Hematop. 2024.

Kambara Y, Fujii N, Usui Y, Yamamoto A, Higo H, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, et al. Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2022.